Jeff Geschwind, MD: Innovator in Cancer Drug Development Founder of Cage Pharma, Jeff Geschwind, MD, focuses on targeting cancer metabolism to create novel drugs. His research on glycolysis inhibition offers new hope for treating aggressive tumors. https://www.eurekalert.org/multimedia/645474